Cencora Inc., a drug-distribution giant based in Conshohocken, is expanding its presence in oncology and retina care, two medical specialties that rely heavily on pharmaceuticals. The company ...

Discover how effective market segmentation identifies profitable customers and optimizes pricing, distribution, and product ...

The "Narcolepsy Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering.Senior leaders in the narcolepsy treatment market face an industry defined by ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs in the U.S.

Relevant Industrial, a provider of industrial equipment and engineered solutions, acquired Lindberg Process Equipment, a provider of industrial heating and combustion systems. The acquisition ...

Merck & Co., Inc. (NYSE:MRK) is one of the stocks Jim Cramer discussed, along with the tech battleground. Cramer highlighted the company’s strategic planning for when Keytruda loses patent protection.

The MarketWatch News Department was not involved in the creation of this content. Bozen, Italy--(Newsfile Corp. - December 5, 2025) - Transfeero ends 2025 as one of the strongest years in its history, ...

Halozyme HALO-1.20%decrease; red down pointing triangle was granted a preliminary injunction that would prevent Merck MRK 1.42%increase; green up pointing triangle & Co. from distributing a ...

Nov 18 (Reuters) - Global drugmakers are rushing to boost U.S. manufacturing and inventory as the Trump administration weighs a 100% tariff on imported branded and patented drugs. Although enforcement ...

Merck & Co. is spending $9.2 billion for Cidara Therapeutics and its lead influenza antiviral that was dropped by Johnson & Johnson last year. Merck is paying $221.50 cash per share of Cidara, a San ...

Merck & Co. and Eisai previously had high hopes for their Keytruda-Lenvima combination in a liver cancer subtype based on positive progression-free survival data, but now the combo’s promise has once ...